- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 211/36 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Patent holdings for IPC class C07D 211/36
Total number of patents in this class: 67
10-year publication summary
|
7
|
5
|
9
|
7
|
1
|
2
|
5
|
3
|
3
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2718 |
13 |
| Toray Industries, Inc. | 7038 |
3 |
| Eisai R&D Management Co., Ltd. | 1183 |
3 |
| Novo Nordisk A/S | 2299 |
3 |
| The Regents of the University of California | 20534 |
2 |
| ABAC Therapeutics S.L. | 7 |
2 |
| The Broad Institute, Inc. | 1927 |
2 |
| Constellation Pharmaceuticals, Inc. | 213 |
2 |
| Seqirus Inc. | 256 |
2 |
| Bristol-myers Squibb Company | 4812 |
1 |
| F. Hoffmann-La Roche AG | 7835 |
1 |
| AstraZeneca AB | 2836 |
1 |
| AstraZeneca UK Limited | 558 |
1 |
| Bayer AG | 3435 |
1 |
| Massachusetts Institute of Technology | 10196 |
1 |
| The General Hospital Corporation | 4809 |
1 |
| Henkel AG & Co. KGaA | 10715 |
1 |
| Amicus Therapeutics, Inc. | 356 |
1 |
| Amyris, Inc. | 365 |
1 |
| Baruch S. Blumberg Institute | 36 |
1 |
| Other owners | 24 |